A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing

Psychopharmacology

Volumn 137, Issue 2, 1998, Pages 147-156

  Carriero, D ^a   Aberman, J ^a   Lin, S Y ^a   Hill, A ^a   Makriyannis, A ^a   Salamone, J D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Anandamide; Catalepsy; Motor; Response initiation; Tetrahydrocannabinol; THC

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; DELTA8 TETRAHYDROCANNABINOL; METHANANDAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVERAGING; BEHAVIOR; CATALEPSY; DRUG EFFECT; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; MOTOR CONTROL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; ARACHIDONIC ACIDS; CONDITIONING, OPERANT; CYCLOHEXANOLS; MALE; MORPHOLINES; NAPHTHALENES; RATS; TETRAHYDROCANNABINOL;

EID: 0031969546     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050604     Document Type: Article

References (48)

1. Adams R, Lowew, S, Jelinek, C, Wolff H (1941) Tetrahydrocannabinol homologs with marihuana activity. J Acad Chem Soc 63: 1971-1978
2. 2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res 691: 106-114
3. Boyd ES, Hutchinson ED, Gardner LC, Merrit DA (1963) Effects of tetrahydrocannabinol and other drugs on operant behavior in rats. Arch Int Pharmacodyn 144: 533-554
4. Bruning JL, Kintz BL (1987) Computational handbook of statistics. Scott, Foresman and Co., Glenview, Ill.
5. Carriero DL (1997) A detailed characterization of the response-suppressing effects of cannabinoid, neuroleptic, sedative and cholinomimetic drugs. Masters Thesis, University of Connecticut
6. Carriero DL, Outslay G, Mayorga AJ, Aberman JE, Gianutsos G, Salamone JD (1997) Motor dysfunction produced by tacrine administration in rats. Pharmacol Biochem Behav 58: 851-858
7. Compton DR, Johnson MR, Melvin LS, Martin BR (1991) Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther 260: 201-209
8. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 263: 1118-1126
9. Compton DR, Rice KC, de Costa DR, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218-226
10. Cook SA, Welch SP, Lichtman AH, Martin BR (1995) Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sci 56: 2049-2056
11. Cousins MS, Salamone JD (1996a) Involvement of ventrolateral striatum dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neurosci 70: 849-859
12. Cousins MS, Salamone JD (1996b) Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Res 732: 186-194
13. Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613
14. Faustmun WO, Fowler SC (1981) Use of operant response duration to distinguish between the effects of haloperidol and non-reward. Pharmacol Biochem Behav 15: 327-329
15. 2 (raclopride) antagonists. Psychopharmacology 115: 24-30
16. 8-trans-tetrahydrocannabinol and cannabinol on schedule-controlled behavior of pigeons and rats. J Pharmacol Exp Ther 178:241-252
17. Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646-1648
18. Gerard WA, Mollereau C, Vassart G, Parmentier M (1990) Nucleotide sequence of human cannabinoid receptor cDNA. Nucleic Acids Res 18: 7142
19. 9-Tetrahydrocannabinol and the extrapyramidal system. Psychopharmacology 54: 87-99
20. 9-THC in the rat. Neuropharmacology 17: 137-144
21. Herkenham M, Lynn MD, Little AB, Johnson MK, Melvin LS, de Costa BR (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936
22. Herkenham M, Lynn AB, de Costa BR, Richfield EK (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547: 267-274
23. 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination. Neuropharmacology 28: 183-189
24. Hohmann AG, Martin WJ, Tsou K, Walker JM (1995) Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci 56: 2111-2118
25. Keppel G (1982) Design and analysis: a researchers handbook. Prentice-Hall, Englewood Cliffs, NJ.
26. Liao RM, Fowler SC (1990) Haloperidol produces within-session increments in operant response duration in rats. Pharmacol Biochem Behav 36: 199-201
27. Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intra-hippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282-290
28. Makriyannis A, Rapaka RS (1990) Minireview: the molecular basis of cannabinoid activity. Life Sci 47: 2173-2184
29. Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL (1981) Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sci 29: 565-574
30. Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471-478
31. Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM (1995) An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci 56: 2103-2109
32. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564
33. Miller AS, Walker JM (1995) Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur J Pharmacol 279: 179-185
34. 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergtc alterations. Pharmacol Biochem Behav 45:291-298
35. Paule MG, Allen RR, Bailey JR, Scallet AC, Ali SF, Brown RM, Slikker W Jr (1991) Chronic marijuana smoke exposure in the rhesus monkey II: effects on progressive ratio and conditioned position responding. J Pharmacol Exp Ther 260: 210-222
36. 9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 27: 1265-1270
37. 9-tetrahydrocannabinol. Pharmacol Biochem Behav 40: 581-585
38. 9-THC in the rat. Psychopharmacology 107: 117-124
39. Richter A, Loscher W (1994) (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. Eur J Pharmacol 264: 371-377
40. 8-tetrahydrocannabinol-dimethyl heptyl-induced catalepsy in male rats. Neuropharm Neurotox 5: 761-765
41. Romero J, Garcia L, Cebeira M, Zadrozny D, Fernandez-Ruiz JJ, Ramos JA (1995) The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci 56: 2033-2040
42. 1 receptor ligand. Life Sci 58: 1249-1257
43. Salamone JD, Kurth P, McCullough LD, Sokolowski JD (1993a) The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: contrasts with the effects of extinction. Pharmacol Biochem Behav 50: 437-443
44. Salamone JD, Kurth PA, McCullough LD, Sokolowski JD (1993b) The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res 628:218-226
45. Sokolowski JD, Salamone JD (1994) Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res 642: 20-28
46. Souilhac J, Poncelet M, Carmona-Rinaldi M, Le Fur G, Soubrié P (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol Biochem Behav 51: 3-7
47. Smith JB (1991) Situational specificity of tolerance to decreased operant responding by morphine and 1-nantadol. Psychopharmacology 103: 115-120
48. Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR (1995) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34: 669-676